Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Insmed Inc (NASDAQ: INSM) closed at $72.75 down -0.22% from its previous closing price of $72.91. In other words, the price has decreased by -$0.22 from its previous closing price. On the day, 1.56 million shares were traded. INSM stock price reached its highest trading level at $74.62 during the session, while it also had its lowest trading level at $72.075.
Ratios:
For a deeper understanding of Insmed Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.61 and its Current Ratio is at 1.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on April 23, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $55 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 10 ’24 when Flammer Martina M.D. sold 21,195 shares for $60.00 per share. The transaction valued at 1,271,700 led to the insider holds 106,134 shares of the business.
Schaeffer Orlov S Nicole sold 55,000 shares of INSM for $3,043,150 on Jun 03 ’24. The Chief People Strategy Officer now owns 108,760 shares after completing the transaction at $55.33 per share. On May 30 ’24, another insider, Flammer Martina M.D., who serves as the Chief Medical Officer of the company, sold 21,195 shares for $55.00 each. As a result, the insider received 1,165,725 and left with 106,134 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 11866907648 and an Enterprise Value of 11606703104. For the stock, the TTM Price-to-Sale (P/S) ratio is 37.18. Its current Enterprise Value per Revenue stands at 36.789 whereas that against EBITDA is -17.275.
Stock Price History:
Over the past 52 weeks, INSM has reached a high of $78.87, while it has fallen to a 52-week low of $20.94. The 50-Day Moving Average of the stock is 17.67%, while the 200-Day Moving Average is calculated to be 104.30%.
Shares Statistics:
For the past three months, INSM has traded an average of 3.57M shares per day and 1580500 over the past ten days. A total of 161.23M shares are outstanding, with a floating share count of 156.79M. Insiders hold about 2.75% of the company’s shares, while institutions hold 91.56% stake in the company. Shares short for INSM as of 1721001600 were 14868059 with a Short Ratio of 4.17, compared to 1718323200 on 11568176. Therefore, it implies a Short% of Shares Outstanding of 14868059 and a Short% of Float of 9.25.
